Akash Kedia, Managing Director – Healthcare and Lifesciences, Alvarez & Marsal India, and Amit Misra, Managing Director – Healthcare and Lifesciences, Alvarez & Marsal India, share their insights on the transformative trends shaping the Indian pharmaceutical landscape.
In an exclusive interview with Express Pharma, they provide expert insights on:
- CDMO valuations and their evolving significance
- Strategies to navigate regulatory challenges
- Global trade realignments and their impact
- The sector’s shift towards innovation and frontier market opportunities
- Unlocking the next levers of value creation
Read the full interview here
This article is an Intellectual Property of Express Pharma
Strategic Agility for Healthcare Leaders: Building Resilience Amid Disruption
January 12, 2026
The healthcare industry stands at a critical crossroads, grappling with an era of profound disruption and uncertainty. Over the past two decades, the pace of change has accelerated dramatically, reshaping the competitive landscape and challenging the ability of all stakeholders to adapt.
Provider-Sponsored Health Plans: Bridge or Anchor?
December 17, 2025
Provider-sponsored health plans are no longer neutral—they either create enterprise value or drain capital. This analysis gives CFOs and CEOs a clear framework to decide whether to scale, partner, restructure, or exit.
The 2026 Transformation Imperative- Integrated Strategies for Hospitals, Health Systems and Provider-Sponsored Health Plans
November 13, 2025
The next 12–18 months will test hospital and health system leaders like never before. Transformation isn’t a buzzword anymore—it’s the work that will define who thrives in 2026 and beyond.
